No Result
View All Result
  • Login
Thursday, August 6, 2026
theadvisertimes.com
  • Home
  • Business
  • Financial Planning
  • Personal Finance
  • Investing
  • Money
  • Economy
  • Markets
  • Stocks
  • Trading
  • Home
  • Business
  • Financial Planning
  • Personal Finance
  • Investing
  • Money
  • Economy
  • Markets
  • Stocks
  • Trading
No Result
View All Result
theadvisertimes.com
No Result
View All Result
Home Markets

Archer-Daniels-Midland (ADM) Has a Processing-and-Biofuels Recovery Story Bigger Than a Commodity Trade

by theadvisertimes.com
2 months ago
in Markets
Reading Time: 3 mins read
A A
0
Archer-Daniels-Midland (ADM) Has a Processing-and-Biofuels Recovery Story Bigger Than a Commodity Trade
Share on FacebookShare on TwitterShare on LInkedIn


Archer-Daniels-Midland (ADM) is easy to dismiss as a low-multiple agricultural commodity processor whose earnings rise and fall with crush spreads and trade conditions. That description is not entirely wrong, but it is incomplete. The latest quarter shows a business with several profit pools improving at different speeds, and management’s raised full-year outlook suggests the recovery case is being driven by more than a generic bounce in crop markets.

The headline numbers were not spectacular, but they were solid enough to support a better thesis. ADM reported first-quarter 2026 earnings per share of $0.62 and adjusted EPS of $0.71. Total segment operating profit was $764 million, up 2% from a year earlier, while net earnings were $298 million and adjusted net earnings were $345 million. That matters because it points to a business whose internal mix is improving even before every segment is fully back in form.

Related Coverage

The most important point is that ADM’s earnings base is not coming from one line item. Ag Services and Oilseeds segment operating profit declined to $273 million from $412 million a year earlier, and the biggest drag inside that group was Crushing, which swung to a $79 million loss from a $47 million profit. On the surface, that supports the bear case that ADM is still too exposed to volatile processing economics. But that is only one part of the quarter.

Elsewhere, the results were notably better. Carbohydrate Solutions segment operating profit rose to $356 million from $240 million, helped by Starches and Sweeteners at $229 million versus $207 million and Vantage Corn Processors at $127 million versus $33 million. Nutrition operating profit increased to $135 million from $95 million, with Human Nutrition at $104 million and Animal Nutrition at $31 million. Those are important numbers because they show ADM’s earnings mix can improve even when one major processing bucket remains under pressure.

Management’s own explanation reinforces that view. In the company’s first-quarter release, CEO Juan Luciano said crushing and ethanol benefited from a constructive biofuels environment, while Nutrition improved on higher Flavors sales, recovery at the Decatur East plant, and continued gains in Animal Nutrition. That combination matters because it ties the quarter to specific operational and policy drivers rather than leaving investors with a vague hope that the cycle is turning.

The revenue picture in the 10-Q also supports a more nuanced read. ADM reported first-quarter revenue of $16.001 billion in Ag Services and Oilseeds and $2.559 billion in Carbohydrate Solutions, alongside additional contribution from Nutrition. Those figures underline the scale of the network. This is a very large origination, processing, transport, and value-added manufacturing platform. When higher-margin categories like sweeteners, flavors, and selected nutrition lines improve at the same time that biofuels conditions get more constructive, the quality of the earnings mix can change faster than a simple commodity narrative implies.

That is why the guidance raise matters. ADM lifted its full-year 2026 adjusted EPS outlook to $4.15 to $4.70 from $3.60 to $4.25. Management said the higher range reflects expected earnings improvement primarily in crushing and ethanol following finalization of the 2026 and 2027 renewable volume obligations under the U.S. Renewable Fuels Standard. In plain English, policy clarity is now helping the company lean into businesses where better economics were hard to underwrite a few months ago.

Balance-sheet flexibility also helps the case. ADM ended March with $591 million in cash and cash equivalents, alongside substantial inventory and processing assets embedded in a very large working-capital system. This is not a pristine, asset-light company, but it does not need to be. The point is that the company has the scale, infrastructure, and segment diversity to absorb weakness in one lane while waiting for better conditions in another.

The risk is that investors have heard this kind of recovery argument before, and ADM is still exposed to trade flows, policy shifts, energy costs, and margin volatility. Crushing was weak enough in the quarter to remind everyone that the model does not smooth out overnight. If biofuels policy support proves less durable or processing margins retrace, the raised guidance could look optimistic.

Still, the latest quarter suggests the stock deserves to be viewed as more than a cheap commodity processor. ADM has a sprawling physical network, an improving contribution from carbohydrate and nutrition businesses, and a more supportive ethanol and crushing backdrop than it had earlier in the cycle. That combination does not remove cyclicality, but it does make the earnings recovery story broader and more investable than the market’s shorthand often implies.

Key Signals for Investors

Carbohydrate Solutions profit of $356 million and Nutrition profit of $135 million show that earnings diversification is doing real work while Ag Services and Oilseeds remains uneven.
Crushing staying weak at a $79 million operating loss is still the biggest near-term risk to the recovery thesis and the most important segment to watch in coming quarters.

Sources

ADM first-quarter 2026 results release: https://investors.adm.com/news/news-details/2026/ADM-Reports-First-Quarter-2026-Results/default.aspx
Archer-Daniels-Midland Quarterly Report on Form 10-Q for quarter ended March 31, 2026: https://www.sec.gov/Archives/edgar/data/7084/000000708426000023/adm-20260331.htm



Source link

Tags: ADMArcherDanielsMidlandBiggerCommodityProcessingandBiofuelsRecoveryStorytrade
ShareTweetShare
Previous Post

US stocks today: Dow soars 800 points to hit record as Iran optimism offsets chip slump, weak jobs data

Next Post

IBM, AT&T accused by whistleblower of covering up foreign hacks

Related Posts

GH Research Releases Q2 2026 Financial Results

GH Research Releases Q2 2026 Financial Results

by theadvisertimes.com
August 6, 2026
0

AlphaStreet Newsdesk powered by AlphaStreet Intelligence GHRS|EPS -$0.23|Net Loss $15.1M GH Research PLC reported a wider quarterly loss as the...

HHS Decertifies Kentucky Organ Donation Group Over Safety Concerns

HHS Decertifies Kentucky Organ Donation Group Over Safety Concerns

by theadvisertimes.com
August 6, 2026
0

LOUISVILLE — The U.S. Department of Health and Human Services said on Aug. 5 that it is moving to decertify...

Global Food Prices Will Soar And Acute Hunger Will Spike Thanks To A Shocking Confluence Of Disastrous Events

Global Food Prices Will Soar And Acute Hunger Will Spike Thanks To A Shocking Confluence Of Disastrous Events

by theadvisertimes.com
August 5, 2026
0

by MichaelExperts are warning that a historic global food crisis has begun. Food prices have already been rising for years,...

As Warsh and the Fed contemplate fewer meetings, markets brace for potential volatility ahead

As Warsh and the Fed contemplate fewer meetings, markets brace for potential volatility ahead

by theadvisertimes.com
August 5, 2026
0

Federal Reserve Chairman Kevin Warsh speaks during a news conference at the William McChesney Martin Jr. Federal Reserve Board Building...

Highlights of McKesson’s (MCK) Q1 2027 earnings report

Highlights of McKesson’s (MCK) Q1 2027 earnings report

by theadvisertimes.com
August 5, 2026
0

McKesson Corporation (NYSE: MCK) on Wednesday reported an increase in revenue and earnings for the first quarter of fiscal 2027....

Wall Street’s ‘fear gauge’ is doing something unusual as stocks hit record highs

Wall Street’s ‘fear gauge’ is doing something unusual as stocks hit record highs

by theadvisertimes.com
August 5, 2026
0

Traders work on the floor of the New York Stock Exchange. NYSETuesday's rally was so intense that it's shaking up...

Next Post
IBM, AT&T accused by whistleblower of covering up foreign hacks

IBM, AT&T accused by whistleblower of covering up foreign hacks

Audible Discount: One FREE Month!

Audible Discount: One FREE Month!

  • Trending
  • Comments
  • Latest
SEC pushes private market access, but retail is already in

SEC pushes private market access, but retail is already in

July 16, 2026
How I Maximize My Sapphire Reserve Dining Credit

How I Maximize My Sapphire Reserve Dining Credit

July 10, 2026
The Weekly Notable Startup Funding Report: 6/22/26 – AlleyWatch

The Weekly Notable Startup Funding Report: 6/22/26 – AlleyWatch

June 21, 2026
The 10 Largest NYC Tech Startup Funding Rounds of June 2026 – AlleyWatch

The 10 Largest NYC Tech Startup Funding Rounds of June 2026 – AlleyWatch

July 6, 2026
The Weekly Notable Startup Funding Report: 7/20/26 – AlleyWatch

The Weekly Notable Startup Funding Report: 7/20/26 – AlleyWatch

July 20, 2026
The Hidden Cost of Chaos: Challenges with Spreadsheet-Based Channel Management in 2026

The Hidden Cost of Chaos: Challenges with Spreadsheet-Based Channel Management in 2026

May 6, 2026
Trump’s Commerce Department as Venture Capitalist: Political Investment at its Worst

Trump’s Commerce Department as Venture Capitalist: Political Investment at its Worst

0
Britannia Q1 Results: Profit rises 14% to Rs 593 crore on volumes, price rise

Britannia Q1 Results: Profit rises 14% to Rs 593 crore on volumes, price rise

0
Your Processes Are The Weakest Part Of Your AEO Strategy

Your Processes Are The Weakest Part Of Your AEO Strategy

0
OraSure expects Q3 revenue of .5M-.5M while delaying InteliQuick CT/NG FDA clearance beyond 2026 (NASDAQ:OSUR)

OraSure expects Q3 revenue of $29.5M-$32.5M while delaying InteliQuick CT/NG FDA clearance beyond 2026 (NASDAQ:OSUR)

0
Coinbase Lets UK Users Trade US Stocks While Wall Street Sleeps

Coinbase Lets UK Users Trade US Stocks While Wall Street Sleeps

0
When ‘Feelings Are Data’ To Navigate Clients’ Financial Planning Trade-Offs: Kitces & Carl 196

When ‘Feelings Are Data’ To Navigate Clients’ Financial Planning Trade-Offs: Kitces & Carl 196

0
Britannia Q1 Results: Profit rises 14% to Rs 593 crore on volumes, price rise

Britannia Q1 Results: Profit rises 14% to Rs 593 crore on volumes, price rise

August 6, 2026
OraSure expects Q3 revenue of .5M-.5M while delaying InteliQuick CT/NG FDA clearance beyond 2026 (NASDAQ:OSUR)

OraSure expects Q3 revenue of $29.5M-$32.5M while delaying InteliQuick CT/NG FDA clearance beyond 2026 (NASDAQ:OSUR)

August 6, 2026
GH Research Releases Q2 2026 Financial Results

GH Research Releases Q2 2026 Financial Results

August 6, 2026
Your Processes Are The Weakest Part Of Your AEO Strategy

Your Processes Are The Weakest Part Of Your AEO Strategy

August 6, 2026
Ooredoo teams up with Nvidia and Nokia to launch 1 GW AI platform in Indonesia

Ooredoo teams up with Nvidia and Nokia to launch 1 GW AI platform in Indonesia

August 6, 2026
Dell Technologies (DELL): Steht der Mega-Ausbruch kurz bevor?

Dell Technologies (DELL): Steht der Mega-Ausbruch kurz bevor?

August 6, 2026
theadvisertimes.com

Get the latest news and follow the coverage of Business & Financial News, Stock Market Updates, Analysis, and more from the trusted sources.

CATEGORIES

  • Business
  • Cryptocurrency
  • Economy
  • Financial Planning
  • Investing
  • Market Analysis
  • Markets
  • Money
  • Personal Finance
  • Startups
  • Stock Market
  • Trading

LATEST UPDATES

  • Britannia Q1 Results: Profit rises 14% to Rs 593 crore on volumes, price rise
  • OraSure expects Q3 revenue of $29.5M-$32.5M while delaying InteliQuick CT/NG FDA clearance beyond 2026 (NASDAQ:OSUR)
  • GH Research Releases Q2 2026 Financial Results
  • Our Great Privacy Policy
  • Terms of Use, Legal Notices & Disclosures
  • About Us
  • Contact Us

© Copyright 2024 All Rights Reserved
See articles for original source and related links to external sites.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Home
  • Business
  • Financial Planning
  • Personal Finance
  • Investing
  • Money
  • Economy
  • Markets
  • Stocks
  • Trading

© Copyright 2024 All Rights Reserved
See articles for original source and related links to external sites.